Your browser doesn't support javascript.
loading
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer.
Ray-Coquard, Isabelle; Cibula, David; Mirza, Mansoor R; Reuss, Alexander; Ricci, Caterina; Colombo, Nicoletta; Koch, Horst; Goffin, Frédéric; González-Martin, Antonio; Ottevanger, Petronella B; Baumann, Klaus; Bjørge, Line; Lesoin, Anne; Burges, Alexander; Rosenberg, Per; Gropp-Meier, Martina; Harrela, Maija; Harter, Philipp; Frenel, Jean-Sébastien; Minarik, Tomas; Pisano, Carmela; Hasenburg, Annette; Merger, Michael; du Bois, Andreas.
Afiliación
  • Ray-Coquard I; GINECO and Medical Oncology Department, Centre Léon Bérard, University Claude Bernard Lyon, Lyon, France.
  • Cibula D; AGO and Oncogynecologic Center, Department of Obstetrics and Gynecology, General Faculty Hospital, Charles University of Prague, Prague, Czech Republic.
  • Mirza MR; NSGO and Department of Oncology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
  • Reuss A; AGO and Coordinating Center for Clinical Trials, Philipps-University of Marburg, Marburg, Germany.
  • Ricci C; MITO and Division of Gynecologic Oncology, Department of Women and Children's Health and Public Health, Fondazione Policlinico Gemelli IRCCS, Rome, Italy.
  • Colombo N; MaNGO and European Institute of Oncology and University of Milan Bicocca, Milan, Italy.
  • Koch H; AGO Austria and Department of Obstetrics and Gynecology, Paracelsus Medical University, Salzburg, Austria.
  • Goffin F; BGOG and CHU de Liège, University of Liège, Liège, Belgium.
  • González-Martin A; GEICO and Medical Oncology Department, Clínica Universidad de Navarra, Madrid, Spain.
  • Ottevanger PB; DGOG and Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Baumann K; AGO and Department of Gynecology, Klinikum der Stadt Ludwigshafen GmbH, Ludwigshafen, Germany.
  • Bjørge L; NSGO and Department of Gynecology, Haukeland Universitetssykehus, Bergen, Norway.
  • Lesoin A; Center for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Burges A; GINECO and Department of Gynecologic Cancer and Medical Oncology, Centre Oscar Lambret, Lille, France.
  • Rosenberg P; AGO and Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Germany.
  • Gropp-Meier M; NSGO and Department of Oncology, University Hospital Linköping, Linköping, Sweden.
  • Harrela M; AGO and Department of Gynecology and Obstetrics, Oberschwabenklinik, Krankenhaus St. Elisabeth, Ravensburg, Germany.
  • Harter P; NSGO and Department of Gynoncology and Gynecology and Obstetrics, Kymenlaakso Central Hospital, Kotka, Finland.
  • Frenel JS; AGO and Department of Gynecology and Gynecologic Oncology, Kliniken Essen Mitte, Essen, Germany.
  • Minarik T; GINECO and Centre René Gauducheau, Institut de Cancerologie de l'Ouest, Saint Herblain, France.
  • Pisano C; NSGO and National Institute of Oncology, Bratislava, Slovakia.
  • Hasenburg A; MITO and Department of Uro-Gynecologic Oncology, Istituto Nazionale per Io Studio e la Cura dei Tumori 'Fondazione G. Pascale' IRCCS, Naples, Italy.
  • Merger M; AGO and Department of Obstetrics and Gynecology, University Medical Center, Mainz, Germany.
  • du Bois A; Oncology Medicine, Boehringer Ingelheim International GmbH, Biberach, Germany.
Int J Cancer ; 146(2): 439-448, 2020 01 15.
Article en En | MEDLINE | ID: mdl-31381147
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Protocolos de Quimioterapia Combinada Antineoplásica / Inhibidores de Proteínas Quinasas / Indoles Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Int J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Protocolos de Quimioterapia Combinada Antineoplásica / Inhibidores de Proteínas Quinasas / Indoles Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Int J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Francia